ArticleJournal for immunotherapy of cancer2022

Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models.

Marilin S Koch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.